(Q37791482)

23 August 2017

title

The microtubule as a breast cancer target (English)

1 reference

23 August 2017

Gerald M. Higa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20862571

18 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20862571

18 July 2024

publication date

23 September 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s12282-010-0224-7.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

http://link.springer.com/article/10.1007/s12282-010-0224-7/fulltext.html

18 July 2024

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

http://link.springer.com/content/pdf/10.1007/s12282-010-0224-7

18 July 2024

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

18 July 2024

1 reference

23 August 2017

volume

18

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

103-119

1 reference

23 August 2017

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Structure of the alpha beta tubulin dimer by electron crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Molecular chaperones: towards a characterization of the heat-shock protein 70 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

AIM-1: a mammalian midbody-associated protein required for cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

High-resolution model of the microtubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Microtubule polymerization dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Asymmetric behavior of severed microtubule ends after ultraviolet-microbeam irradiation of individual microtubules in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Structural insights into microtubule function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Vinblastine suppresses dynamics of individual microtubules in living interphase cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Localization of the vinblastine-binding site on beta-tubulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: evidence of possible age bias?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Expression of oncogenic epidermal growth factor receptor family kinases induces paclitaxel resistance and alters beta-tubulin isotype expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Differential expression of alternatively spliced forms of MAP4: a repertoire of structurally different microtubule-binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Maytansine binding to the vinblastine sites of tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Paclitaxel-induced cell death: where the cell cycle and apoptosis come together

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Gr

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Cardiac function following combination therapy with paclitaxel and doxorubicin: an analysis of 657 women with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

A systematic review of taxane-containing regimens for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Adjuvant docetaxel for node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Integrity of actin fibers and microtubules influences metastatic tumor cell adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Vinca alkaloids: anti-vascular effects in a murine tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Evaluation of antivascular and antimitotic effects of tubulin binding agents in solid tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

ZD6126: a novel small molecule vascular targeting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Delivery of newly synthesized tubulin to rapidly growing distal axons of sympathetic neurons in compartmented cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Historical vignette of Cajal's work "Degeneration and regeneration of the nervous system" with a reflection of the author.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Axon growth: roles of microfilaments and microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Cytoskeletal Dynamics and Transport in Growth Cone Motility and Axon Guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Mechanisms of disease: the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Association of high-molecular-weight proteins with microtubules and their role in microtubule assembly in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

EXCESSIVE GROWTH OF THE SYMPATHETIC GANGLIA EVOKED BY A PROTEIN ISOLATED FROM MOUSE SALIVARY GLANDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Microtubule nucleation by gamma-tubulin-containing rings in the centrosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

On the role of aurora-A in centrosome function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Epothilones induce human colon cancer SW620 cell apoptosis via the tubulin polymerization independent activation of the nuclear factor-kappaB/IkappaB kinase signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

The protein kinase B/Akt signalling pathway in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Gene-expression analysis and the basal-like breast cancer subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Neuronal microtubules: when the MAP is the roadblock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12282-010-0224-7

21 January 2018

Molecular Pharmacology

11

36

366

WD Singer

1989

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma

18 July 2024

14

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy

18 July 2024

16

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

18 July 2024

19

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Antimitotic Activity of the Potent Tumor Inhibitor Maytansine

18 July 2024

30

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Tumor inhibitors. 124. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids

18 July 2024

33

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

18 July 2024

Cancer clinical trials

34

1

113

RH Blum

1978

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Early Clinical Study of an Intermittent Schedule for Maytansine (NSC-153858): Brief Communication 2

18 July 2024

35

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines

18 July 2024

45

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death

18 July 2024

46

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells

18 July 2024

47

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer

18 July 2024

48

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma.

18 July 2024

49

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial.

18 July 2024

52

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic

18 July 2024

53

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer

18 July 2024

54

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

18 July 2024

56

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial

18 July 2024

58

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial

18 July 2024

59

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

18 July 2024

66

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial

18 July 2024

67

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone

18 July 2024

71

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine

18 July 2024

73

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy

18 July 2024

74

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

18 July 2024

75

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: evidence for dynamic interactions of tau with microtubules in vivo

18 July 2024

88

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Neurofilament proteins are distributed in a diminishing proximodistal gradient along rat sciatic nerve

18 July 2024

92

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection

18 July 2024

95

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit

18 July 2024

101

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion.

18 July 2024

103

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

18 July 2024

Science city

108

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

18 July 2024

118

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

MEK inhibition enhances paclitaxel-induced tumor apoptosis

18 July 2024

123

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

Blockade of the phosphatidylinositol-3-kinase-Akt signaling pathway enhances the induction of apoptosis by microtubule-destabilizing agents in tumor cells in which the pathway is constitutively activated

18 July 2024

136

1 reference

https://api.crossref.org/works/10.1007/S12282-010-0224-7

18 July 2024

Identifiers

1 reference

23 August 2017

1 reference